Leading the Way in Computational Biology Services

Solve Real Drug Discovery Questions

CD ComputaBio brings together experts in computational biology, AI-assisted drug discovery, structural biology, molecular modeling, medicinal chemistry, and validation strategy. We help clients identify targets, explain binding mechanisms, optimize leads, evaluate antibody developability, and prioritize candidates through workflows that connect scientific questions with practical R&D decisions.

AI-Powered Discovery Platform

CD ComputaBio integrates advanced algorithms, AI models, molecular simulation workflows, and biological data analysis pipelines into a flexible discovery service system. Our technology capabilities support structure modeling, molecular interaction prediction, virtual screening, drug design, antibody and protein engineering, omics-driven biomarker analysis, and mechanism research.

AI-to-Experiment Closed-Loop

As an AI-to-experiment drug discovery CRO, CD ComputaBio focuses on turning computational insights into actionable experimental decisions. Our deliverables support candidate ranking, interaction analysis, structural interpretation, mechanism hypothesis generation, risk assessment, and validation-ready reporting for downstream experimental planning.